Literature DB >> 28063633

Evaluation of Myocardial Strain in Patients With Amyloidosis Using Cardiac Magnetic Resonance Feature Tracking.

Tarun Pandey1, Sindhura Alapati2, Vibhor Wadhwa2, Mohan M Edupuganti3, Pooja Gurram3, Shelly Lensing4, Kedar Jambhekar2.   

Abstract

PURPOSE: To study the use of cardiac magnetic resonance (CMR) feature tracking technique in evaluation of myocardial amyloidosis.
MATERIALS AND METHODS: CMR scans of 28 patients with biopsy proven myocardial amyloidosis and 35 controls were reviewed. Conventional short axis, vertical long axis, and 4-chamber cine steady-state free precession images from CMR scans were used to generate radial, circumferential, and longitudinal myocardial strain maps using feature tracking software. Global and regional peak radial, circumferential, and longitudinal strain values were computed.
RESULTS: There were significant decreases in radial, circumferential, and longitudinal strains in patients with myocardial amyloidosis globally and across layers (all P < 0.001). Strain was relatively preserved for the apex and most affected for the basal level. The area under the receiver operating characteristic curve for base peak radial, circumferential, and longitudinal strain 0.899, 0.884, and 0.866 and cut offs of 22.9, -13.3, and -10.9, respectively, were determined by receiver operating characteristic analysis. CMR feature tracking strain analysis of base-level strain parameters was able to differentiate patients with myocardial amyloidosis from those without myocardial amyloid with high sensitivity (82.5%) and specificity (82.9%) particularly for radial strain. The maximum sensitivity (89.3%) was achieved if any of the 3 parameters were abnormal, and the maximum specificity (88.6%) when all 3 parameters were abnormal.
CONCLUSION: Myocardial amyloidosis produces significant changes in regional and global strain parameters, and the peak radial and circumferential strain are the most affected at the basal layer.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2016        PMID: 28063633     DOI: 10.1067/j.cpradiol.2016.11.008

Source DB:  PubMed          Journal:  Curr Probl Diagn Radiol        ISSN: 0363-0188


  6 in total

1.  Contrast-enhanced echocardiographic measurement of longitudinal strain: accuracy and its relationship with image quality.

Authors:  Ilya Karagodin; Davide Genovese; Eric Kruse; Amit R Patel; Nina Rashedi; Roberto M Lang; Victor Mor-Avi
Journal:  Int J Cardiovasc Imaging       Date:  2019-11-13       Impact factor: 2.357

2.  Potential clinical relevance of cardiac magnetic resonance to diagnose cardiac light chain amyloidosis.

Authors:  Zsofia Dohy; Liliana Szabo; Zoltan Pozsonyi; Ibolya Csecs; Attila Toth; Ferenc Imre Suhai; Csilla Czimbalmos; Andrea Szucs; Anna Reka Kiss; David Becker; Bela Merkely; Hajnalka Vago
Journal:  PLoS One       Date:  2022-06-13       Impact factor: 3.752

3.  Segmental strain for scar detection in acute myocardial infarcts and in follow-up exams using non-contrast CMR cine sequences.

Authors:  Malgorzata Polacin; Mihaly Karolyi; Matthias Eberhard; Ioannis Matziris; Hatem Alkadhi; Sebastian Kozerke; Robert Manka
Journal:  BMC Cardiovasc Disord       Date:  2022-05-18       Impact factor: 2.174

4.  Cardiac Magnetic Resonance Predicting Outcomes Among Patients at Risk for Cardiac AL Amyloidosis.

Authors:  Ali M Agha; Nicolas Palaskas; Amit R Patel; Jeanne DeCara; Purvi Parwani; Cezar Iliescu; Jean B Durand; Peter Kim; Saamir Hassan; Gregory Gladish; Hans C Lee; Gregory P Kaufman; Juan C Lopez-Mattei
Journal:  Front Cardiovasc Med       Date:  2021-06-29

Review 5.  Multi-modality imaging in transthyretin amyloid cardiomyopathy.

Authors:  Bryan Paul Traynor; Aamir Shamsi; Victor Voon
Journal:  World J Cardiol       Date:  2019-11-26

Review 6.  The Role of Multi-modality Imaging in the Diagnosis of Cardiac Amyloidosis: A Focused Update.

Authors:  Shaun Khanna; Ivy Wen; Aditya Bhat; Henry H L Chen; Gary C H Gan; Faraz Pathan; Timothy C Tan
Journal:  Front Cardiovasc Med       Date:  2020-10-30
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.